IPHA

Innate Pharma Sa

1.850

-0.020-1.07%

After Hours: 1.850 0.000 0.00%17:57 09/14 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.850/1.850

TODAY RANGE1.840-1.920

VOL47.79K

MARKET CAP207.76M

52 WEEK RANGE1.170-2.710

AVG VOL (3M)144.59K

% TURNOVER0.04%

TURNOVER--

P/E (TTM)-2.8873

% RANGE4.32%

EPS(TTM)-0.6442

P/E(FORWARD)-4.5146

P/B-6.8433

BVPS-0.2718

DIVIDEND--

P/S53.30

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP204.85M

SHARES OUTSTANDING111.70M

NEXT EARNINGS--

FREE FLOAT110.14M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·09/02 10:30
Analysts Offer Insights on Healthcare Companies: Guardant Health (GH), NRX Pharmaceuticals (NRXP) and Innate Pharma (IPHA)
Dow Jones·08/12 09:39
Innate Pharma Price Target Raised to $9.00/Share From $8.00 by BTIG
Dow Jones·08/12 09:39
Innate Pharma Is Maintained at Buy by BTIG
TipRanks·08/11 11:20
Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO), Spyre Therapeutics (SYRE) and Innate Pharma (IPHA)
TipRanks·08/11 10:20
Leerink upgrades Innate Pharma to Outperform after lacutamab deal
TipRanks·08/11 10:15
Innate Pharma upgraded to Outperform from Market Perform at Leerink
Dow Jones·08/10 18:14
Innate Pharma Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·08/10 18:14
Innate Pharma Price Target Raised to $7.00/Share From $5.00 by HC Wainwright & Co.
TipRanks·08/10 16:30
Innate Pharma price target raised to $7 from $5 at H.C. Wainwright
NASDAQ·08/10 12:29
Pre-Market Most Active for Aug 10, 2026 : SPCX, ACHR, ABCL, SION, INTC, IPHA, SLN, CHMI, NOK, HZO, B, IONQ
Seeking Alpha·08/10 11:36
At a glance: stocks gapping up premarket
NASDAQ·08/10 10:21
Innate Pharma Jumps After Sobi Deal To Advance Lacutamab Into Phase 3; Appoints Markus Jensen As CMO
TipRanks·08/10 09:30
Innate Pharma, Sobi to enable initiation of the TELLOMAK-3 study
TipRanks·08/10 09:30
Innate Pharma CMO Sonia Quaratino to depart, Markus Jensen to succeed
NASDAQ·08/10 07:10
Sobi, Innate Join To Conduct TELLOMAK-3 Phase 3 Confirmatory Trial In Cutaneous T-cell Lymphoma

Same Industry

Name/Symbol

Change%

Price

Innate Pharma Sa

IPHA

-1.07%

1.850

Regeneron Pharmaceuticals

REGN

-1.48%

781.49

GRDX

BNTX

United Therapeutics Corp.

UTHR

-1.34%

497.11

Vertex Pharmaceuticals Inc

VRTX

+0.17%

515.44

SIGA

Moderna

MRNA

+5.38%

143.97

Charles Riv Labs Intl Inc

CRL

+1.93%

278.26

Medpace Holdings

MEDP

+0.75%

587.52

TLPH

ICON plc

ICLR

+2.08%

172.45

CBPO

Iqvia Hldgs Inc

IQV

+1.74%

261.77

MOLECULAR PARTNERS AG

MOLN

0.00%

4.180

Arcturus Therape

ARCT

+5.36%

14.73

Gilead Sciences Inc

GILD

+1.87%

146.41

PRAH

INCY

Aptevo Therapeutics Inc

APVO

-0.55%

1.820

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.